Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nicholas Healthcare is an Indian pharmaceutical company and a wholly-owned subsidiary of Akums Drugs & Pharmaceuticals, specializing in the marketing and distribution of branded generic medicines. The company offers a diverse portfolio across key therapeutic segments, including anti-infectives, gastroenterology, cardiology, diabetology, and orthopedics. Leveraging the "Nicholas" legacy brand, it provides high-quality, GMP-certified products such as proton pump inhibitors, anti-diabetics, and specialized dermatological treatments. Nicholas Healthcare operates an extensive distribution network across India, aiming to improve access to affordable and effective healthcare solutions. The company is supported by the robust manufacturing and R&D capabilities of its parent organization, Akums, to maintain high standards of safety and efficacy.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nicholas.